Luo, Qiu-yun
Yang, Jing
Di, Tian
Xia, Zeng-fei
Zhang, Lin
Pan, Wen-tao
Shi, Shan
Yang, Li-qiong
Sun, Jian
Qiu, Miao-zhen
Yang, Da-jun
Article History
Received: 21 June 2024
Accepted: 20 October 2024
First Online: 26 November 2024
Competing interests
: DJY holds ownership interests, including patents, in Ascentage Pharma Group Corp. Limited. WTP is an employee of Ascentage Pharma Group Corp. Limited. The remaining authors have no potential conflicts of interest to disclose.
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethical Review Committee of Sun Yat-sen University Cancer Center (B2022-633-01). Informed written consent was obtained from all participants. The in vivo animal experiments were approved by the animal experimentation ethics committee and carried out under the guidance of the Sun Yat-Sen University Committee for the Use and Care of Laboratory Animals (Approval number: L102012022110I).
: All the authors have read and approved the manuscript.